Pharmacoepidemiological Analysis Of The Costs Of Changing Antiretroviral Therapy Regimen In Hiv-Infected Patients In The Syrian Arab Republic

Volume 20 No 17 (2022)

Gushchina Y.S., Haitham Yuones, Zyryanov S.K, Korovyakova Elina., Albawareed A.A.

DOI: 10.14704/Nq.2022.20.17.Nq88012

Abstract

The aim of the study was to optimize the approach to the treatment of HIV-infected patients in the Syrian Arab Republic based on data from the pharmacoeconomic analysis. The frequency of changing the original HIV treatment regimen was high and was due to adverse drug reactions in 48.5% of cases. The change in the cost of treatment when replacing antiretroviral therapy regimens depending on the reason for the replacement was analyzed. In addition, the cost of various 1st, 2nd and 3rd line antiretroviral therapy regimens was studied. The results of pharmacoeconomic analysis performed can be used to select the initial antiretroviral therapy regimen and replace it if necessary

Keywords

HIV, antiretroviral therapy, costs, pharmacoeconomic analysis, Syrian Arab Republic

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.